164 related articles for article (PubMed ID: 30257201)
1. Precision Targeting of BFL-1/A1 and an ATM Co-dependency in Human Cancer.
Guerra RM; Bird GH; Harvey EP; Dharia NV; Korshavn KJ; Prew MS; Stegmaier K; Walensky LD
Cell Rep; 2018 Sep; 24(13):3393-3403.e5. PubMed ID: 30257201
[TBL] [Abstract][Full Text] [Related]
2. Crystal Structures of Anti-apoptotic BFL-1 and Its Complex with a Covalent Stapled Peptide Inhibitor.
Harvey EP; Seo HS; Guerra RM; Bird GH; Dhe-Paganon S; Walensky LD
Structure; 2018 Jan; 26(1):153-160.e4. PubMed ID: 29276033
[TBL] [Abstract][Full Text] [Related]
3. Selective Covalent Targeting of Anti-Apoptotic BFL-1 by Cysteine-Reactive Stapled Peptide Inhibitors.
Huhn AJ; Guerra RM; Harvey EP; Bird GH; Walensky LD
Cell Chem Biol; 2016 Sep; 23(9):1123-1134. PubMed ID: 27617850
[TBL] [Abstract][Full Text] [Related]
4. Selective Covalent Targeting of Anti-apoptotic BFL-1 by a Sulfonium-Tethered Peptide.
Liu N; Wang D; Lian C; Zhao R; Tu L; Zhang Y; Liu J; Zhu H; Yu M; Wan C; Li D; Li S; Yin F; Li Z
Chembiochem; 2021 Jan; 22(2):340-344. PubMed ID: 32790056
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Covalent Molecular Inhibitor of Anti-apoptotic BFL-1 by Disulfide Tethering.
Harvey EP; Hauseman ZJ; Cohen DT; Rettenmaier TJ; Lee S; Huhn AJ; Wales TE; Seo HS; Luccarelli J; Newman CE; Guerra RM; Bird GH; Dhe-Paganon S; Engen JR; Wells JA; Walensky LD
Cell Chem Biol; 2020 Jun; 27(6):647-656.e6. PubMed ID: 32413285
[TBL] [Abstract][Full Text] [Related]
6. hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents.
Barile E; Marconi GD; De SK; Baggio C; Gambini L; Salem AF; Kashyap MK; Castro JE; Kipps TJ; Pellecchia M
ACS Chem Biol; 2017 Feb; 12(2):444-455. PubMed ID: 28026162
[TBL] [Abstract][Full Text] [Related]
7. Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 Proteins.
Kump KJ; Miao L; Mady ASA; Ansari NH; Shrestha UK; Yang Y; Pal M; Liao C; Perdih A; Abulwerdi FA; Chinnaswamy K; Meagher JL; Carlson JM; Khanna M; Stuckey JA; Nikolovska-Coleska Z
J Med Chem; 2020 Mar; 63(5):2489-2510. PubMed ID: 31971799
[TBL] [Abstract][Full Text] [Related]
8. Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737.
Mathieu AL; Sperandio O; Pottiez V; Balzarin S; Herlédan A; Elkaïm JO; Fogeron ML; Piveteau C; Dassonneville S; Deprez B; Villoutreix BO; Bonnefoy N; Leroux F
J Biomol Screen; 2014 Aug; 19(7):1035-46. PubMed ID: 24809353
[TBL] [Abstract][Full Text] [Related]
9. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
Modi V; Lama D; Sankararamakrishnan R
J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of BCL2A1/Bfl-1 protein: Potential stock in cancer therapy.
Li X; Dou J; You Q; Jiang Z
Eur J Med Chem; 2021 Aug; 220():113539. PubMed ID: 34034128
[TBL] [Abstract][Full Text] [Related]
11. A redox switch regulates the structure and function of anti-apoptotic BFL-1.
Korshavn KJ; Wales TE; Bird GH; Engen JR; Walensky LD
Nat Struct Mol Biol; 2020 Sep; 27(9):781-789. PubMed ID: 32661419
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of Bfl-1/A1 via NF-kappaB activation in cisplatin-resistant human bladder cancer cell line.
Kim JK; Kim KD; Lee E; Lim JS; Cho HJ; Yoon HK; Cho MY; Baek KE; Park YP; Paik SG; Choe YK; Lee HG
Cancer Lett; 2004 Aug; 212(1):61-70. PubMed ID: 15246562
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a selective and covalent small-molecule inhibitor of BFL-1 protein that induces robust apoptosis in cancer cells.
Feng X; Yan Z; Zhou F; Lou J; Lyu X; Ren X; Zeng Z; Liu C; Zhang S; Zhu D; Huang H; Yang J; Zhao Y
Eur J Med Chem; 2022 Jun; 236():114327. PubMed ID: 35385805
[TBL] [Abstract][Full Text] [Related]
14. The Bcl-2 family member Bfl-1/A1 is strongly repressed in normal and malignant plasma cells but is a potent anti-apoptotic factor for myeloma cells.
Tarte K; Jourdan M; Veyrune JL; Berberich I; Fiol G; Redal N; Shaughnessy J; Klein B
Br J Haematol; 2004 May; 125(3):373-82. PubMed ID: 15086420
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of Bfl-1 protein expression sensitizes malignant B cells to apoptosis.
Brien G; Trescol-Biemont MC; Bonnefoy-Bérard N
Oncogene; 2007 Aug; 26(39):5828-32. PubMed ID: 17353899
[TBL] [Abstract][Full Text] [Related]
16. Characterization of peptide aptamers targeting Bfl-1 anti-apoptotic protein.
Brien G; Debaud AL; Bickle M; Trescol-Biemont MC; Moncorge O; Colas P; Bonnefoy-Berard N
Biochemistry; 2011 Jun; 50(23):5120-9. PubMed ID: 21563784
[TBL] [Abstract][Full Text] [Related]
17. The anti-apoptotic Bcl-2 family protein A1/Bfl-1 regulates neutrophil survival and homeostasis and is controlled via PI3K and JAK/STAT signaling.
Vier J; Groth M; Sochalska M; Kirschnek S
Cell Death Dis; 2016 Feb; 7(2):e2103. PubMed ID: 26890142
[TBL] [Abstract][Full Text] [Related]
18. Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist.
Simmons MJ; Fan G; Zong WX; Degenhardt K; White E; Gélinas C
Oncogene; 2008 Feb; 27(10):1421-8. PubMed ID: 17724464
[TBL] [Abstract][Full Text] [Related]
19. Tertiary Structural Motif Sequence Statistics Enable Facile Prediction and Design of Peptides that Bind Anti-apoptotic Bfl-1 and Mcl-1.
Frappier V; Jenson JM; Zhou J; Grigoryan G; Keating AE
Structure; 2019 Apr; 27(4):606-617.e5. PubMed ID: 30773399
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Bfl-1/A1 in leukemia cells undergoing differentiation by all-trans retinoic acid treatment attenuates chemotherapeutic agent-induced apoptosis.
Xia L; Wurmbach E; Waxman S; Jing Y
Leukemia; 2006 Jun; 20(6):1009-16. PubMed ID: 16572199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]